Session Chair Profile
M.D., Chief Medical Officer, Cota Healthcare Inc.
Stuart Goldberg MD is Chief Medical Officer at Cota, Inc. and Associate Clinical Professor of Medicine at Rutgers at the New Jersey Medical School. He also maintains an active clinical practice in the Division of Leukemia at the John Theurer Cancer Center. Dr. Goldberg obtained his medical degree at the Pennsylvania State University and fellowships in hematology-oncology and bone marrow transplantation at George Washington University Medical Center and Mayo Clinic. In the field of “big data” analysis he has used Medicare and MarketScan databases to redefine the incidence and complications related with myelodysplastic syndromes (published in JCO and Transfusion) and has reviewed observational databases (including SIMPLICITY) to foster adherence with evidence-based CML monitoring guidelines (published in JOP, CRMO and CLML). Most recently, he has used the Cota database to explore rates and implications of EGFR mutational testing among community oncologists and cost-effectiveness of genomic profiling in lower-risk breast cancer.
Session Synopsis: Value-based care models in complex diseases like cancer hold the most promise for being able to increase patient outcomes and lower the overall total cost of care. This session will explain how the secret to enabling the creation of successful value-based models is a precision data approach using Electronic Health Record data, with examples from a pilot between one of the country’s largest cancer centers and a large payer.